ClinicalTrials.govpublic full text
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma
squamous cell carcinoma, head and neck cancer, recurrent disease, scchn, recurrent, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907319
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.